Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Gains from Investment Securities (2018 - 2025)

Fennec Pharmaceuticals filings provide 8 years of Gains from Investment Securities readings, the most recent being -$159000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 337.31% to -$159000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$45000.0, a 128.12% decrease, with the full-year FY2025 number at $283000.0, down 10.44% from a year prior.
  • Gains from Investment Securities hit -$159000.0 in Q4 2025 for Fennec Pharmaceuticals, down from $31000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.0 million in Q3 2023 to a low of -$159000.0 in Q4 2025.
  • Median Gains from Investment Securities over the past 5 years was $188000.0 (2024), compared with a mean of $1.8 million.
  • Biggest five-year swings in Gains from Investment Securities: surged 15793.33% in 2024 and later crashed 337.31% in 2025.
  • Fennec Pharmaceuticals' Gains from Investment Securities stood at $4.3 million in 2021, then plummeted by 99.34% to $28000.0 in 2022, then increased by 25.0% to $35000.0 in 2023, then skyrocketed by 91.43% to $67000.0 in 2024, then crashed by 337.31% to -$159000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$159000.0 (Q4 2025), $31000.0 (Q3 2025), and $100000.0 (Q2 2025) per Business Quant data.